Randox Laboratories
Success
You have successfully submitted your enquiry. Someone from our company will respond ASAP
Randox Laboratories
Press Releases
FDA approves the Randox ConcizuTrace™ ELISA Companion Diagnostic (CDx)
Randox Laboratories announced that the U.S. Food and Drug Administration (FDA) has approved the De Novo application for the company’s first Companion Diagnostic (CDx). This is a major achievement for Randox following over 3 years of innovative development and collaboration with Novo Nordisk. The Companion Diagnostic was developed as a new option for determining the amount of medication a patient with hemophilia has received.